Search

Search Results

• Temporal Changes in Lung Cancer: A 10-year Study in a Chest Hospital

  H. Halilcolar, S. Yapicioglu, S. Bilaceroglu

  2016-01-26

  https://doi.org/10.4081/monaldi.2008.377

  712

  PDF: 487
• 

  Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report

  Paola Maria Medusa , Marina Gilli, Luca Notizia, Raffaella Pagliaro, Nicola Carro, Alessandro Moriello, Vito D'Agnano, Andrea Bianco, Fabio Perrotta, Fabiana Vitiello

  2022-11-25

  https://doi.org/10.4081/monaldi.2022.2440

  1449

  PDF: 352

• Weekly chemotherapy with cisplatin and paclitaxel in advanced NSCLC: a phase II study

  G. Buccheri, D. Ferrigno, M.C. Giordano

  2016-02-15

  https://doi.org/10.4081/monaldi.2006.568

  717

  PDF: 480
• 

  Can serum progranulin level be used as a prognostic biomarker in non-small cell lung cancer?

  Nevin Taci Hoca, Ebru Ünsal, Koza Murat, Arzu Ertürk, Nermin Çapan

  2022-11-14

  https://doi.org/10.4081/monaldi.2022.2373

  1031

  PDF: 229

• The usefulness of transesophageal echocardiography in the staging of locally advanced lung cancer

  U. Caterino, G. Dialetto, F.E. Covino, G. Mazzarella, E. Grella, M. Massimo

  2016-02-03

  https://doi.org/10.4081/monaldi.2007.508

  609

  PDF: 504

• Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: an implementation study

  T. Berghmans, A-P Meert, V. Ninane, J-P Sculier

  2005-12-30

  https://doi.org/10.4081/monaldi.2005.619

  884

  PDF: 436
• 

  Statistical approach to mediastinal staging in NSCLC with M.E.S.S.i.a. software

  Thomas Galasso, Lorenzo Corbetta, Laura Mancino, Lucio Michieletto, Loris Ceron

  2019-09-10

  https://doi.org/10.4081/monaldi.2019.1068

  1345

  PDF: 696

• Pulmonary Rehabilitation in lung cancer

  F. Pasqua, K. Geraneo, I. Nardi, F. Lococo, A. Cesario

  2015-11-25

  https://doi.org/10.4081/monaldi.2013.95

  2514

  PDF: 1563

• Programmed cell death-ligand 1 expression and CD8 positive tumor-infiltrating lymphocyte density in non-small cell lung carcinoma and its association with histopathological grading

  Niti Sureka, Sheetal Arora, Pranav Ish, Geetika Khanna

  2025-02-21

  https://doi.org/10.4081/monaldi.2025.3288

  413

  PDF_EARLY VIEW: 118

• Common epidermal growth factor receptor mutations in north Indian patients with non-small cell lung carcinoma: evidence from real-time polymerase chain reaction

  Rakesh Behera, Sheetal Arora, Pranav Ish, Geetika Khanna

  2024-10-25

  https://doi.org/10.4081/monaldi.2024.3202

  1095

  PDF_EARLY VIEW: 176

• Survival among patients with lung cancer managed at a tertiary care center in North India

  Rahul Kumar, Dipti Gothi, Shweta Anand, Shazia Khan, Nipun Malhotra

  2024-07-26

  https://doi.org/10.4081/monaldi.2024.3045

  607

  PDF_EARLY VIEW: 304
• 

  ROS1 positive non-small cell lung cancer with pulmonary embolism in a 22-year woman

  Ananda Datta, Satya Padmaja Mantha, Suvradeep Mitra, Prasanta Raghab Mohapatra, M Srikanth Goud, Manoj Kumar Panigrahi

  2020-08-07

  https://doi.org/10.4081/monaldi.2020.1435

  823

  PDF: 529
• 

  Non-small cell lung cancer presenting as "psoas muscle syndrome": a case report

  Mariano Mollica, Rosalba Maffucci, Sabrina Lavoretano, Gaetano Rea, Francesco Saverio Cerqua, Luigi Aronne, Andrea Bianco, Fabio Perrotta

  2019-04-05

  https://doi.org/10.4081/monaldi.2019.1012

  1854

  PDF: 1086
• 

  Detection of clinically-relevant EGFR variations in de novo small cell lung carcinoma by droplet digital PCR

  Rajesh Venkataram, Vijith Shetty, Kishan Prasad, Sonam Kille, Teerthanath Srinivas, Anirban Chakraborty

  2022-09-02

  https://doi.org/10.4081/monaldi.2022.2280

  1150

  PDF: 451
• 

  Quantitative analysis of cell-free DNA by droplet digital PCR reveals the presence of EGFR mutations in non-malignant lung pathologies

  Rajesh Venkataram, Srividya Arjuna, Giridhar Belur Hosmane, Anirban Chakraborty

  2021-05-04

  https://doi.org/10.4081/monaldi.2021.1748

  1946

  PDF: 652
• 

  Alectinib rescue therapy in advanced ALK rearranged lung adenocarcinoma: a case report

  Cristiano Cesaro, Umberto Caterino, Fabio Perrotta, Umberto Masi, Alessandra Cotroneo, Roberta Cianci, Enzo Zamparelli, Flavio Cesaro, Dario Amore, Danilo Rocco

  2022-09-20

  https://doi.org/10.4081/monaldi.2022.2388

  1406

  PDF: 259
• 

  Interstitial nephritis secondary to treatment with pembrolizumab, a rare complication in two patients with lung adenocarcinoma

  Diana Alexandra Gonçalves Pimenta, Renata Carvalho, Raquel Pereira, Rui Rolo, Lurdes Ferreira

  2022-07-28

  https://doi.org/10.4081/monaldi.2022.2368

  1065

  PDF: 412
• 

  Subtyping of advanced lung cancer based on PD-L1 expression, tumor histopathology and mutation burden (EGFR and KRAS): a study from North India

  Ritu Kulshrestha, Himanshi Saxena, Raj Kumar, Sonam Spalgais, Parul Mrigpuri, Nitin Goel, Balakrishnan Menon, Meenu Rani, Pawan Mahor, Ishita Bhutani

  2023-02-01

  https://doi.org/10.4081/monaldi.2023.2449

  1352

  PDF: 350